Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortization of Deferred ChargesCapital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesDeferred TaxesDepreciation & Amortization (CF)Depreciation & Amortization (CF)Exchange Rate EffectExchange Rate EffectFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesLong-Term Debt IssuancesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Orthofix Medical (OFIX) Gains from Investment Securities (2016 - 2026)

Orthofix Medical has reported Gains from Investment Securities over the past 17 years, most recently at $31000.0 for Q1 2026.

  • For the quarter ending Q1 2026, Gains from Investment Securities fell 97.7% year-over-year to $31000.0, compared with a TTM value of $4.2 million through Mar 2026, down 31.35%, and an annual FY2025 reading of $993000.0, up 31.7% over the prior year.
  • Gains from Investment Securities came in at $31000.0 for Q1 2026, down from $5.3 million in the prior quarter.
  • In the past five years, Gains from Investment Securities ranged from a high of $19.8 million in Q4 2022 to a low of -$10.7 million in Q2 2022.
  • Median Gains from Investment Securities over the past 5 years was $500000.0 (2023), compared with a mean of $1.6 million.
  • The largest YoY upside for Gains from Investment Securities was 13839.44% in 2022 against a maximum downside of 580.25% in 2022.
  • Over 5 years, Gains from Investment Securities stood at $19.8 million in 2022, then crashed by 67.18% to $6.5 million in 2023, then crashed by 104.74% to -$308000.0 in 2024, then soared by 1831.17% to $5.3 million in 2025, then tumbled by 99.42% to $31000.0 in 2026.
  • Per Business Quant, the three most recent readings for OFIX's Gains from Investment Securities are $31000.0 (Q1 2026), $5.3 million (Q4 2025), and -$427000.0 (Q3 2025).